Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $350,395 (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 47.6%

Value ($000) $166,634 Shares 28,195,249 Est. Cost $7.32 Unrealized -9.5%

BVS BIOVENTUS 44.4%

Value ($000) $155,605 Shares 13,021,324 Est. Cost $13.37 Unrealized -35.3%

EYPT EYEPOINT PHARMACEUTICALS INC 3.5%

Value ($000) $12,397 Shares 1,551,521 Est. Cost $4.68 Unrealized +87.6%

TELA TELA BIO, INC. 3.0%

Value ($000) $10,400 Shares 4,110,709 Est. Cost $11.82 Unrealized -69.9%

— REVANCE THERAPEUTICS INC 0.7%

Value ($000) $2,372 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 0.7%

Value ($000) $2,322 Shares 1,105,941 Est. Cost $2.95 Unrealized -49.8%

— VENUS CONCEPT, INC. 0.2%

Value ($000) $665 Shares 1,089,190 Est. Cost $0.69 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	28,195,249	$166,634	47.6%	$7.32	-9.5%	COM	602496101
BVS	BIOVENTUS	13,021,324	$155,605	44.4%	$13.37	-35.3%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	1,551,521	$12,397	3.5%	$4.68	+87.6%	COM NEW	30233G209
TELA	TELA BIO, INC.	4,110,709	$10,400	3.0%	$11.82	-69.9%	COM	872381108
—	REVANCE THERAPEUTICS INC	457,085	$2,372	0.7%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$2,322	0.7%	$2.95	-49.8%	COM NEW	58468P206
—	VENUS CONCEPT, INC.	1,089,190	$665	0.2%	$0.69	—	COM	92332W204